A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation
Clinical trial NCT06045806 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06045806
- Sponsor
- Celgene
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-16
- Primary completion
- 2025-08-11
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.